Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

September 02, 2016

As the United States and other member countries of the G20 meet in Hangzhou, China, September 4-5, Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to address the failures of medical research and development (R&D) to deliver medicines, vaccines and diagnostics that match the health needs of people around the world instead of only focusing on the most lucrative products.

May 26, 2016

New York/Ise-Shima/Geneva—As the leaders of the G7 countries gather in Ise-Shima, Japan over the next two days, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to make a bold commitment to prioritize a better global response to public health emergencies and to take action to encourage the research and development (R&D) and affordable pricing of critical medicines.

April 21, 2016

The earthquakes that ratted southwestern Japan last week injured around 1,100 people in Kumamoto and Oita prefectures and led to the deaths of another 58. Roughly 103,000 people remained displaced in Kumamoto and around 600 in Oita, and the authorities are still searching for people who are unaccounted for as well. What's more, due to heavy rains and the subsequent risk of landslides, some 240,000 people have been advised to evacuate 19 cities, towns and villages in Kumamoto and Oita.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

June 19, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) has learned that the Chinese patent office has just denied Gilead Science’s request for a key patent on the hepatitis C drug sofosbuvir. This drug, together with other antivirals, is the backbone of several newer, more effective curative treatments for hepatitis C, yet is exorbitantly priced in many countries, restricting access for people who need it. Hepatitis C is a global public health crisis, with at least 150 million people living with the disease, and 350,000-500,000 people die each year from complications of it.

June 29, 2011

Stories include: MSF teams treating wounded people in Misrata, Libya; the need for mental healthcare to survivors of Japan's tsunami; the new treatment target set by the United Nations to reach 15 million people living with HIV by 2015; and amendments to French law that suspend the ability of foreigners to get a temporary right of residence, which could create a public health risk.  

June 13, 2011

MSF will assist the construction of two temporary clinics in the tsunami-afflicted Miyagi and Iwate prefectures. 

May 09, 2011

Two months after the massive earthquake and tsunami hit northeast Japan, MSF psychologists are continuing to work with survivors.

April 15, 2011

Doctors Without Borders/Médecins Sans Frontières (MSF) teams are providing medical and psychological care to survivors of the earthquake and tsunami disaster that struck northeastern Japan on March 11, 2011. The national response to the disaster has been massive, so MSF is focussed on meeting the needs of small pockets of the population in remote areas.

All photos © Giulio Di Sturco/VII mentor

April 05, 2011

A team of six MSF psychologists have started working with the survivors of the massive earthquake and tsunami that hit northeast Japan on March 11.

Pages